On Monday, September 30, 2019, the U.S. Food and Drug Administration (FDA) approved a new indication for the Janssen Pharmaceutical Companies of Johnson & Johnson's INVOKANA (canagliflozin) to treat diabetic kidney disease and reduce the risk of hospitalization for heart failure in patients with Type 2 diabetes and diabetic nephropathy.

As a person with diabetes, you need to pay extra attention to them! Even the smallest of problems could get worse and lead to more serious complications in the future.

You're not alone! Work on feeling better physically and emotionally. Here's some advice and strategies for your encounter with complications.

Adults with diabetes are nearly twice as likely to die from heart disease or stroke. Learn more about the risks of heart disease and Type 2 diabetes.